People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other Technology, Software / Tech, Other Health Care, AI / ML, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mesosphere, Inc. | — | Other Technology | Series D+ | $198.6M | $4.0B | 2016 |
| Nova Labs, Inc. | — | Software / Tech | Series D+ | $168.6M | $2.6B | 2016 |
| Hello Heart Inc. | — | Other Health Care | Series C | $127.0M | $1.0B | 2021 |
| Rad AI, Inc. | — | AI / ML | Series C | $123.9M | $623.2M | 2024 |
| Big Switch Networks, Inc. | — | Other Technology | Series B | $100.4M | $630.8M | 2012 |
| Ginger.io, Inc. | — | Software / Tech | Series C | $99.1M | $1.5B | 2019 |
| Bay Labs, Inc. | — | Software / Tech | Series C | $68.9M | $1.7B | 2020 |
| Arevo, Inc. | — | Other Technology | Series C | $41.7M | $1.3B | 2020 |
| Gitlab Inc. | — | Computers | Series B | $24.5M | $686.5M | 2015 |
| Pivotlink Corp | — | Other Technology | Series A | $12.6M | $55.5M | 2011 |
Bruce Armstrong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce Armstrong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jon Callaghan | 1 | 20 |
| Peter Levine | 1 | 11 |
| Alex Morgan | 1 | 10 |
| Mark Leslie | 1 | 9 |
| Shirish Sathaye | 1 | 9 |
| Gordon Ritter | 1 | 8 |
| Somesh Dash | 1 | 8 |
| DEBORAH FARRINGTON | 1 | 7 |
| Brian Shin | 1 | 7 |
| Stuart Peterson | 1 | 7 |
| Gary Morgenthaler | 1 | 7 |
| Sonny Vu | 1 | 7 |
| David ibnAle | 1 | 7 |
| Joichi Ito | 1 | 7 |
| EVANGELOS SIMOUDIS | 1 | 6 |
| Nick Grossman | 1 | 6 |
| Steve Kraus | 1 | 6 |
| Ron Shah | 1 | 6 |
| Mike Volpi | 1 | 6 |
| Ben Ling | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.